Apollo Endosurgery Completes $50 Million Financing

Tuesday, March 10, 2015 9:00 am CDT
"It is also affirming to us to establish a relationship with such a well-known and respected provider of growth capital to the healthcare industry through this transaction."

AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”), a leader in minimally invasive endoscopic surgical products for bariatric and gastrointestinal procedures, today announced it has closed a $50 million secured term loan provided by Athyrium Capital Management through its Athyrium Opportunities Fund II (together, “Athyrium”).

The secured term loan was used to repay previous borrowings used by Apollo to acquire the obesity intervention division of Allergan, Inc. in December of 2013 and the remaining net proceeds will be used for general corporate purposes.

“The Athyrium financing better aligns our capital structure to the ambitious growth goals we have for Apollo’s business,” said Todd Newton, CEO of Apollo. “It is also affirming to us to establish a relationship with such a well-known and respected provider of growth capital to the healthcare industry through this transaction.”

Richard Pines, a Partner at Athyrium, said, “Athyrium is excited to partner with Apollo during this transformative time in the company’s life. Apollo’s unique portfolio of minimally invasive products addresses the unmet need for treatments that are both more efficacious and safer in the large, growing global obesity market.”

About Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is a leader in minimally invasive endoscopic surgical products for bariatric and gastrointestinal procedures. Apollo Endosurgery was cofounded with the Apollo Group, a unique collaboration of physicians from the Mayo Clinic, Johns Hopkins University, Medical University of South Carolina, the University of Texas Medical Branch and the Chinese University of Hong Kong. This collaboration developed a broad portfolio of patents in the field of endoscopic surgery that became the foundation of Apollo Endosurgery. For more information regarding Apollo Endosurgery, go to: www.apolloendo.com

About Athyrium

Athyrium Capital Management, LP (“Athyrium”) is a specialized asset management company formed in 2008 to focus on investment opportunities in the global healthcare sector. Athyrium is a specialized asset management company with over $1 billion of assets under management. Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations. For more information, please visit www.athyrium.com.

Contact:

Apollo Endosurgery, Inc.
Ted Stephens, 512-279-5100
ted.stephens@apolloendo.com
or
Jen Cook, 512-279-5100
jen.cook@apolloendo.com

Business Wire InvestorHQ℠